Aliases & Classifications for Postherpetic Neuralgia

Aliases & Descriptions for Postherpetic Neuralgia:

Name: Postherpetic Neuralgia 51 69

Summaries for Postherpetic Neuralgia

NINDS : 51 Shingles (herpes zoster) is an outbreak of rash or blisters on the skin that is caused by the same virus that causes chickenpox — the varicella-zoster virus. The first sign of shingles is often burning or tingling pain (which can be severe), or sometimes numbness or itch,generally on one side of the body. After several days or a week, a rash of fluid-filled blisters, similar to chickenpox, appears in one area on one side of the body. Shingles pain can be mild or intense.  Some people have mostly itching; some feel pain from the gentlest touch or breeze.  The most common location for shingles is a band, called a dermatome, spanning one side of the trunk around the waistline. Anyone who has had chickenpox is at risk for shingles.  Scientists think that some of the virus particles from the original exposure to the varicella-zoster virus,leave the skin blisters and move into the nervous system.  When the varicella-zoster virus reactivates, the virus moves back down the long nerve fibers that extend from the sensory cell bodies to the skin.  The viruses multiply, the tell-tale rash erupts, and the person now has shingles.

MalaCards based summary : Postherpetic Neuralgia is related to herpes zoster and neuropathy, and has symptoms including neuralgia and sciatica. An important gene associated with Postherpetic Neuralgia is HLA-B (Major Histocompatibility Complex, Class I, B), and among its related pathways/superpathways are Class I MHC mediated antigen processing and presentation and Cytokine Signaling in Immune system. The drugs Foscarnet and Etoricoxib have been mentioned in the context of this disorder. Affiliated tissues include skin, spinal cord and testes, and related phenotype is Increased shRNA abundance (Z-score > 2).

Wikipedia : 71 Postherpetic neuralgia is a nerve pain due to damage caused by the varicella zoster virus. Typically,... more...

Related Diseases for Postherpetic Neuralgia

Diseases related to Postherpetic Neuralgia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 82)
id Related Disease Score Top Affiliating Genes
1 herpes zoster 11.6
2 neuropathy 10.4
3 diabetic neuropathy 10.2
4 herpes zoster ophthalmicus 10.1
5 neuronitis 10.1
6 immune deficiency, familial variable 10.1 HLA-B HLA-DRB1
7 mirizzi syndrome 10.1 HLA-B HLA-DRB1
8 swine influenza 10.1 HLA-B HLA-DRB1
9 cervical adenoid basal carcinoma 10.1 HLA-B HLA-DRB1
10 cryptococcosis 10.1 HLA-B HLA-DRB1
11 disease of mental health 10.0 HLA-B HLA-DRB1
12 cervicitis 10.0
13 acute cholangitis 10.0 HLA-B HLA-DRB1
14 bacterial meningitis 10.0 HLA-B HLA-DRB1
15 cerebral sarcoidosis 10.0 HLA-A HLA-DRB1
16 respiratory system disease 10.0 HLA-B HLA-DRB1
17 motility-related diarrhea 10.0 HLA-A HLA-DRB1
18 patau syndrome 10.0 HLA-A HLA-DRB1
19 solid pseudopapillary carcinoma of pancreas 10.0 HLA-A HLA-B
20 myopathy, congenital nonprogressive, with moebius sequence and robin sequence 10.0 HLA-A HLA-B
21 epididymo-orchitis 10.0 HLA-A HLA-B
22 aortic coarctation 9.9 HLA-A HLA-B
23 peripheral artery disease 9.9 HLA-A HLA-DRB1
24 bubonic plague 9.9 HLA-A HLA-B
25 colorectal cancer, hereditary nonpolyposis, type 6 9.9 HLA-A HLA-B
26 molybdenum cofactor deficiency a 9.9 HLA-B HLA-DRB1
27 gonococcal endophthalmia 9.9 HLA-A HLA-B
28 spinal cord injury 9.9
29 polyneuropathy 9.9
30 depressed scar 9.9 HLA-A HLA-DRB1
31 mastitis 9.9 HLA-A HLA-B
32 orbital osteomyelitis 9.9 HLA-A HLA-B
33 central nervous system lymphoma 9.9 HLA-A HLA-B
34 autosomal recessive congenital methemoglobinemia 9.9 HLA-A HLA-B
35 b-cell lymphomas 9.9 HLA-A HLA-DRB1
36 psoriasis susceptibility 1 9.9 HLA-A HLA-B
37 atrial septal defect 6 9.9 HLA-A HLA-DRB1
38 pediatric germ cell cancer 9.8 HLA-A HLA-B
39 parotid gland cancer 9.8 HLA-B HLA-DRB1
40 goodpasture syndrome 9.8 HLA-A HLA-B
41 axonal neuropathy 9.8
42 peptic ulcer disease 9.8
43 traumatic brain injury 9.8
44 epidural abscess 9.8
45 heart disease 9.8
46 herpes simplex 9.8
47 horner's syndrome 9.8
48 chickenpox 9.8
49 diabetic polyneuropathy 9.8
50 cardiomyopathy 9.8

Graphical network of the top 20 diseases related to Postherpetic Neuralgia:



Diseases related to Postherpetic Neuralgia

Symptoms & Phenotypes for Postherpetic Neuralgia

UMLS symptoms related to Postherpetic Neuralgia:


neuralgia, sciatica

GenomeRNAi Phenotypes related to Postherpetic Neuralgia according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased shRNA abundance (Z-score > 2) GR00366-A-103 10.53 HLA-B HLA-A
2 Increased shRNA abundance (Z-score > 2) GR00366-A-110 10.53 HLA-B HLA-A
3 Increased shRNA abundance (Z-score > 2) GR00366-A-118 10.53 HLA-B HLA-A
4 Increased shRNA abundance (Z-score > 2) GR00366-A-156 10.53 HLA-B HLA-A
5 Increased shRNA abundance (Z-score > 2) GR00366-A-178 10.53 HLA-B HLA-A
6 Increased shRNA abundance (Z-score > 2) GR00366-A-19 10.53 HLA-B HLA-A
7 Increased shRNA abundance (Z-score > 2) GR00366-A-31 10.53 HLA-B HLA-A
8 Increased shRNA abundance (Z-score > 2) GR00366-A-7 10.53 HLA-A HLA-B
9 Increased shRNA abundance (Z-score > 2) GR00366-A-74 10.53 HLA-A HLA-B

Drugs & Therapeutics for Postherpetic Neuralgia

Drugs for Postherpetic Neuralgia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 175)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Foscarnet Approved Phase 4 63585-09-1, 4428-95-9 3415
2
Etoricoxib Approved, Investigational Phase 4,Phase 2 202409-33-4 123619
3
Menthol Approved Phase 4 2216-51-5 16666
4
Gabapentin Approved, Investigational Phase 4,Phase 3,Phase 2 60142-96-3 3446
5
Carbamazepine Approved, Investigational Phase 4 298-46-4 2554
6
Aspirin Approved, Vet_approved Phase 4,Phase 1 50-78-2 2244
7
Acetaminophen Approved Phase 4,Phase 2 103-90-2 1983
8
Acetylcholine Approved Phase 4,Phase 2 51-84-3 187
9
Capsaicin Approved Phase 4,Phase 3,Phase 2,Phase 1 404-86-4 1548943
10
Lidocaine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 137-58-6 3676
11
Tramadol Approved, Investigational Phase 4 27203-92-5 33741
12
Chlorhexidine Approved, Vet_approved Phase 4 55-56-1 9552079 2713
13
Oxcarbazepine Approved Phase 4 28721-07-5 34312
14
Pregabalin Approved, Illicit, Investigational Phase 4,Phase 3,Phase 2,Phase 1 148553-50-8 5486971
15
Vorapaxar Approved Phase 4 618385-01-6
16
Pitavastatin Approved Phase 4 147511-69-1, 147526-32-7 6366718 5282452
17
Celecoxib Approved, Investigational Phase 4 169590-42-5 2662
18
Phosphonoacetic Acid Experimental Phase 4 4408-78-0 546
19 Acyclovir Phase 4,Phase 3,Phase 2
20 Analgesics Phase 4,Phase 3,Phase 2,Phase 1
21 Narcotics Phase 4,Phase 3,Phase 2
22 Cyclooxygenase 2 Inhibitors Phase 4,Phase 2
23 Cyclooxygenase Inhibitors Phase 4,Phase 2,Phase 1
24 Nucleic Acid Synthesis Inhibitors Phase 4
25 Analgesics, Non-Narcotic Phase 4,Phase 2,Phase 1
26 Analgesics, Opioid Phase 4,Phase 3,Phase 2
27 Anesthetics Phase 4,Phase 3,Phase 2,Phase 1
28 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Phase 1
29 Anti-Infective Agents Phase 4,Phase 3,Phase 2
30 Anti-Inflammatory Agents Phase 4,Phase 2,Phase 1
31 Anti-Inflammatory Agents, Non-Steroidal Phase 4,Phase 2,Phase 1
32 Anti-Retroviral Agents Phase 4
33 Reverse Transcriptase Inhibitors Phase 4
34 Antirheumatic Agents Phase 4,Phase 2,Phase 1
35 Antiviral Agents Phase 4,Phase 3,Phase 2,Phase 1
36 Central Nervous System Depressants Phase 4,Phase 3,Phase 2,Phase 1
37 Chlorhexidine gluconate Phase 4
38 calcium channel blockers Phase 4,Phase 3,Phase 2,Phase 1
39 Cholinergic Agents Phase 4,Phase 2
40 GABA Agents Phase 4,Phase 3,Phase 2
41 Neuromuscular Agents Phase 4,Phase 2
42 Sodium Channel Blockers Phase 4,Phase 2,Phase 3,Phase 1
43 Neurotransmitter Agents Phase 4,Phase 3,Phase 2,Phase 1
44 Neurotransmitter Uptake Inhibitors Phase 4,Phase 3,Phase 2
45 Cytochrome P-450 CYP3A Inducers Phase 4
46 Dermatologic Agents Phase 4,Phase 3,Phase 2,Phase 1
47 Tranquilizing Agents Phase 4,Phase 3,Phase 2,Phase 1
48 Disinfectants Phase 4
49 Diuretics, Potassium Sparing Phase 4,Phase 2,Phase 3,Phase 1
50 Anesthetics, Local Phase 4,Phase 2,Phase 1

Interventional clinical trials:

(show top 50) (show all 197)
id Name Status NCT ID Phase
1 Evaluation of the Efficacy, Tolerability and Safety of Etoricoxib (Arcoxia) in Patients With Neuropathic Pain Unknown status NCT01264237 Phase 4
2 Efficacy and Safety of Foscarnet Sodium and Sodium Chloride Injection in Patients With Herpes Zoster Unknown status NCT02151240 Phase 4
3 Pregabalin for Treatment of Patients With Postherpetic Neuralgia (PHN) Completed NCT01455428 Phase 4
4 Study of Pregabalin Therapy for Pain Relief in Subjects With Post-Herpetic Neuralgia Completed NCT00159666 Phase 4
5 A Study of the Efficacy and Safety of Pregabalin for the Treatment of Diabetic Peripheral Neuropathy or Postherpetic Neuralgia Completed NCT00629681 Phase 4
6 A Study of the Effectiveness And Safety Of Lidoderm® As Add-On Treatment in Patients With Postherpetic Neuralgia, Diabetic Neuropathy, or Low Back Pain Completed NCT00904020 Phase 4
7 Pregabalin Treatment Of Peripheral Neuropathic Pain Associated With Diabetic Peripheral NeP (DPN), Postherpetic Neuralgia (PHN), HIV-related NeP (HIV), and Chemotherapy Induced NeP Completed NCT00407511 Phase 4
8 Safety and Effectiveness of Repeated Administration of QUTENZA Patches for Treatment of Pain Caused by Nerve Damage Completed NCT01252160 Phase 4
9 Efficacy Study of Botox to Treat Neuropathic Pain Completed NCT00527202 Phase 4
10 A Study to Compare QUTENZA With Pregabalin for the Treatment of Peripheral Neuropathic Pain (PNP) After 8 Weeks of Treatment Completed NCT01713426 Phase 4
11 Botulinum Toxin in Peripheral Neuropathic Pain Completed NCT01251211 Phase 4
12 LPHP-Philos-PHN Conservative Treatment Completed NCT00205959 Phase 4
13 Method of Pre-treatment for Application of QUTENZA Capsaicin 8% Patch Completed NCT01416116 Phase 4
14 A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions Completed NCT00904202 Phase 4
15 Oxcarbazepine for the Treatment of Chronic Peripheral Neuropathic Pain Completed NCT01302275 Phase 4
16 Dressing: Frequency of Change and Evaluation of an Antiseptic-Impregnated Catheter Dressing in ICU Patients Completed NCT00417235 Phase 4
17 A Study on Health - Related Quality of Life in Patients With Rheumatic Diseases Taking Tramadol 37.5mg/Acetaminophen 325mg Tablets Completed NCT00642837 Phase 4
18 Acupuncture in Herpes Zoster Neuralgia (ACUZoster) Recruiting NCT00885586 Phase 4
19 Excellence In Peripheral Artery Disease Thrombin Receptor Antagonist Intervention In Claudication Evaluation (XLPAD-TRACE Trial) Recruiting NCT02660866 Phase 4
20 Dyslipidemia of Obesity Intervention in Teens Not yet recruiting NCT02956590 Phase 4
21 Pilot Study Of Pregabalin And Prediction Of Treatment Response In Patients With Postherpetic Neuralgia Terminated NCT01603394 Phase 4
22 Preemptive Analgesia Following Uterine Artery Embolization Terminated NCT01555073 Phase 4
23 Efficacy, Safety, Tolerability and Pharmacokinetics of Concomitant Administration of Tramadol With Duloxetine or Pregabalin Withdrawn NCT01116531 Phase 4
24 Effect of Opioids in Neuropathic Pain in Postherpetic Patients Unknown status NCT01102101 Phase 3
25 A Novel Non Invasive Brain Stimulation Based Treatment for Chronic Low Back Pain (CLBP) Unknown status NCT02393391 Phase 2, Phase 3
26 Safety and Efficacy of Gabapentin in Postherpetic Neuralgia Completed NCT00335933 Phase 3
27 Safety and Efficacy of Gabapentin in Postherpetic Neuralgia Completed NCT00636636 Phase 3
28 Methadone in Post-Herpetic Neuralgia Pain Completed NCT01752699 Phase 3
29 DS-5565 Phase III Study for Post-herpetic Neuralgia Completed NCT02318719 Phase 3
30 Safety And Efficacy Study Of Once Daily Controlled Release Pregabalin In The Treatment Of Patients With Postherpetic Neuralgia Completed NCT01270828 Phase 3
31 Efficacy, Safety and Tolerability Study of TAK-583 in Subjects With Postherpetic Neuralgia Completed NCT00377598 Phase 2, Phase 3
32 A 13-Week, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Postherpetic Neuralgia Completed NCT00394901 Phase 3
33 A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Postherpetic Neuralgia Completed NCT00424372 Phase 3
34 A Confirmatory Study of Fentanyl in Participants With Post-herpetic Neuralgia, Complex Regional Pain Syndrome or Postoperative Pain Syndrome Completed NCT01008553 Phase 3
35 DS-5565 Phase III Study for Renal Impairment in Japanese Subjects Completed NCT02607280 Phase 3
36 To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Postherpetic Neuralgia. Completed NCT00150436 Phase 3
37 Study of NGX-4010 for the Treatment of Postherpetic Neuralgia Completed NCT00115310 Phase 3
38 Study of NGX-4010 for the Treatment of Postherpetic Neuralgia Completed NCT00300222 Phase 3
39 Evaluating E2007 (Perampanel) in Patients With Painful Diabetic Neuropathy (PDN) or Post-Herpetic Neuralgia (PHN) Completed NCT00592904 Phase 2, Phase 3
40 NGX-4010 for the Treatment of Postherpetic Neuralgia Completed NCT00061776 Phase 2, Phase 3
41 Controlled Study of NGX-4010 for the Treatment of Postherpetic Neuralgia Completed NCT00068081 Phase 3
42 Efficacy and Safety of Topical Versus Systemic Treatment in Postherpetic Neuralgia and Diabetic Polyneuropathic Pain Completed NCT00414349 Phase 3
43 Shingles Prevention Study Completed NCT00007501 Phase 3
44 Phase III Randomized Controlled Study of Morphine and Nortriptyline in the Management of Postherpetic Neuralgia Completed NCT00004390 Phase 3
45 Study To Evaluate Efficacy, Safety And Tolerability Of Lyrica In Patients With Painful Diabetic Peripheral Neuropathy Completed NCT01332149 Phase 3
46 Efficacy Study Measuring the Impact of Pregabalin on Peripheral Neuropathic Pain. Completed NCT00219544 Phase 3
47 Effect of Oral Pregabalin on Spinal Neurotransmitters in Patients Undergoing Knee Replacement Completed NCT00729690 Phase 3
48 Study to Evaluate Efficacy, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 70 Years and Older Completed NCT01165229 Phase 3
49 Postoperative Pain and Morphine Consumption After Mastectomy - Lyrica Completed NCT01391858 Phase 3
50 Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg as an Analgesic for Short-Term Treatment in Female Subjects Suffering From Moderate-to-Severe Pain and Burning Upon Urination Associated With Uncomplicated Urinary Tract Infections ( Completed NCT01650051 Phase 3

Search NIH Clinical Center for Postherpetic Neuralgia

Genetic Tests for Postherpetic Neuralgia

Anatomical Context for Postherpetic Neuralgia

MalaCards organs/tissues related to Postherpetic Neuralgia:

39
Skin, Spinal Cord, Testes, Brain, Heart, Dorsal Root Ganglion, T Cells

Publications for Postherpetic Neuralgia

Articles related to Postherpetic Neuralgia:

(show top 50) (show all 583)
id Title Authors Year
1
Cost of shingles: population based burden of disease analysis of herpes zoster and postherpetic neuralgia. ( 28086817 )
2017
2
Effect of Concomitant Pain Medications on Response to Pregabalin in Patients with Postherpetic Neuralgia or Spinal Cord Injury-Related Neuropathic Pain. ( 28072797 )
2017
3
Impact of Data Imputation Methodology on Pain Assessment over 24a88Hours in a Randomized, Placebo-Controlled Study of Gabapentin Enacarbil in Patients with Neuropathic Pain Associated with Postherpetic Neuralgia. ( 26814307 )
2016
4
Shingles (Herpes Zoster) Vaccine (Zostavax(Ar)): A Review in the Prevention of Herpes Zoster and Postherpetic Neuralgia. ( 27189459 )
2016
5
Stellate Ganglion Block for Debilitating Photophobia Secondary to Trigeminal, Postherpetic Neuralgia. ( 27378524 )
2016
6
Association of human leukocyte antigen with postherpetic neuralgia in Koreans. ( 27457498 )
2016
7
Effect of Repetitive Intracutaneous Injections with Local Anesthetics and Steroids for Acute Thoracic Herpes Zoster and Incidence of Postherpetic Neuralgia. ( 27492741 )
2016
8
Relationship between pain relief, reduction in pain-associated sleep interference, and overall impression of improvement in patients with postherpetic neuralgia treated with extended-release gabapentin. ( 27037091 )
2016
9
Pigmented Contact Dermatitis Resulting from Self-medication for Postherpetic Neuralgia. ( 27293266 )
2016
10
Early application of low-level laser may reduce the incidence of postherpetic neuralgia (PHN). ( 27543213 )
2016
11
Epidemiology of Postherpetic Neuralgia in Korea: An Electronic Population Health Insurance System Based Study. ( 27057902 )
2016
12
Modulation of serum BDNF levels in postherpetic neuralgia following pulsed radiofrequency of intercostal nerve and pregabalin. ( 27094801 )
2016
13
Efficacy of Ganglioside GM1 in the Treatment of Postherpetic Neuralgia. ( 27504562 )
2016
14
The efficacy of botulinum toxin for the treatment of trigeminal and postherpetic neuralgia: a systematic review with meta-analyses. ( 27260275 )
2016
15
Microstructural Abnormalities in Gray Matter of Patients with Postherpetic Neuralgia: A Diffusional Kurtosis Imaging Study. ( 27228526 )
2016
16
Impact of topical 5% lidocaine-medicated plasters on sleep and quality of life in patients with postherpetic neuralgia. ( 26821240 )
2016
17
Efficacy of low dose gabapentin in acute herpes zoster for preventing postherpetic neuralgia: a prospective controlled study. ( 26799145 )
2016
18
Efficacy of continuous epidural block in acute herpes zoster: Incidence and predictive factors of postherpetic neuralgia, a retrospective single-center study. ( 27512887 )
2016
19
Bipolar High-Voltage, Long-Duration Pulsed Radiofrequency Improves Pain Relief in Postherpetic Neuralgia. ( 27389115 )
2016
20
Quantification of risk factors for postherpetic neuralgia in herpes zoster patients: A cohort study. ( 27287218 )
2016
21
Price of pain: population-based cohort burden of disease analysis of medication cost of herpes zoster and postherpetic neuralgia. ( 27536159 )
2016
22
The Cost-Effectiveness of Pregabalin Versus Gabapentin for Peripheral Neuropathic Pain (pNeP) and Postherpetic Neuralgia (PHN) in China. ( 26932262 )
2016
23
Factors Associated with Increased Risk for Clinical Insomnia in Patients with Postherpetic Neuralgia: A Retrospective Cross-Sectional Study. ( 27073226 )
2016
24
Fulranumab in Patients with Pain Associated with Postherpetic Neuralgia and Postraumatic Neuropathy: Efficacy, Safety and Tolerability Results from a Randomized, Double-blind, Placebo-controlled, Phase-2 Study. ( 27153360 )
2016
25
Systematic Review and Meta-analysis of the Efficacy of Oral Medications Compared with Placebo Treatment in the Management of Postherpetic Neuralgia. ( 27472529 )
2016
26
A Study on the Connection between the Incidence of Postherpetic Neuralgia and Serum Ionized Calcium. ( 26608994 )
2015
27
Safety and effectiveness of the herpes zoster vaccine to prevent postherpetic neuralgia: 2014 Update and consensus statement from the Canadian Pain Society. ( 25664540 )
2015
28
Combining Botulinum Toxin (A) Injection With Peripheral Nerve Stimulation in a Patient for Intractable Ophthalmic Postherpetic Neuralgia. ( 26033071 )
2015
29
A Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Pregabalin for Postherpetic Neuralgia in a Population of Chinese Patients. ( 26714731 )
2015
30
The clinical significance of infrared thermography for the prediction of postherpetic neuralgia in acute herpes zoster patients. ( 26081167 )
2015
31
Self-regulation of brain activity in patients with postherpetic neuralgia: a double-blind randomized study using real-time FMRI neurofeedback. ( 25848773 )
2015
32
Do Interventional Pain Management Procedures during the Acute Phase of Herpes Zoster Prevent Postherpetic Neuralgia in the Elderly?: A Meta-Analysis of Randomized Controlled Trials. ( 26719654 )
2015
33
Treatment of Postherpetic Neuralgia Using DREZotomy Guided by Spinal Cord Stimulation. ( 25833065 )
2015
34
Ultrasound-Guided Musculocutaneous Nerve Block in Postherpetic Neuralgia. ( 26390394 )
2015
35
Differential myelinated and unmyelinated sensory and autonomic skin nerve fiber involvement in patients with ophthalmic postherpetic neuralgia. ( 26300742 )
2015
36
High-Frequency Repetitive Transcranial Magnetic Stimulation Reduces Pain in Postherpetic Neuralgia. ( 26744887 )
2015
37
Relationships Among Pain Quality, Pain Impact, and Overall Improvement in Patients with Postherpetic Neuralgia Treated with Gastroretentive Gabapentin. ( 26115203 )
2015
38
5% Lidocaine Medicated Plaster for the Treatment of Postherpetic Neuralgia: A Review of the Clinical Safety and Tolerability. ( 25896574 )
2015
39
Varicella-zoster virus-derived major histocompatibility complex class I-restricted peptide affinity is a determining factor in the HLA risk profile for the development of postherpetic neuralgia. ( 25355886 )
2015
40
Is magnesium sulfate effective for pain in chronic postherpetic neuralgia patients comparing with ketamine infusion therapy? ( 25792176 )
2015
41
Herpes zoster and postherpetic neuralgia in Catalonia (Spain). ( 25483532 )
2015
42
Increased Incidence of Herpes Zoster and Postherpetic Neuralgia in Adult Patients following Traumatic Brain Injury: A Nationwide Population-Based Study in Taiwan. ( 26065420 )
2015
43
Predictors of postherpetic neuralgia in patients with herpes zoster: a pooled analysis of prospective cohort studies from North and Latin America and Asia. ( 25841633 )
2015
44
Relationships among Adverse Events, Disease Characteristics, and Demographics in Treatment of Postherpetic Neuralgia with Gastroretentive Gabapentin. ( 25811794 )
2015
45
Risk Factor and Prevention of Postherpetic Neuralgia. ( 26175875 )
2015
46
Mindfulness meditation in older adults with postherpetic neuralgia: A randomized controlled pilot study. ( 25784079 )
2015
47
Diagnosis and management of postherpetic neuralgia. ( 25726617 )
2015
48
Topical and intranasal analgesic therapy in a woman with refractory postherpetic neuralgia. ( 25949241 )
2015
49
5% lidocaine medicated plasters vs. sympathetic nerve blocks as a part of multimodal treatment strategy for the management of postherpetic neuralgia: a retrospective, consecutive, case-series study. ( 25666769 )
2015
50
Assessing The Treatment of Peripheral Neuropathic Pain (Pnep) And Postherpetic Neuralgia (Phn) In China Using A Simulation Model. ( 26533700 )
2015

Variations for Postherpetic Neuralgia

Expression for Postherpetic Neuralgia

Search GEO for disease gene expression data for Postherpetic Neuralgia.

Pathways for Postherpetic Neuralgia

Pathways related to Postherpetic Neuralgia according to GeneCards Suite gene sharing:

(show all 18)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
12.91 HLA-A HLA-B HLA-DRB1
2
Show member pathways
12.82 HLA-A HLA-B HLA-DRB1
3
Show member pathways
12.47 HLA-A HLA-B HLA-DRB1
4
Show member pathways
12.35 HLA-A HLA-B HLA-DRB1
5
Show member pathways
12.27 HLA-A HLA-B HLA-DRB1
6
Show member pathways
12.02 HLA-A HLA-B
7
Show member pathways
11.99 HLA-A HLA-B HLA-DRB1
8 11.98 HLA-A HLA-B
9 11.85 HLA-A HLA-B
10 11.84 HLA-A HLA-B HLA-DRB1
11
Show member pathways
11.72 HLA-A HLA-B
12 11.65 HLA-A HLA-B
13 11.64 HLA-A HLA-B HLA-DRB1
14
Show member pathways
11.55 HLA-A HLA-DRB1
15
Show member pathways
11.51 HLA-A HLA-DRB1
16 11.31 HLA-A HLA-B HLA-DRB1
17 10.96 HLA-A HLA-B HLA-DRB1
18 10.77 HLA-A HLA-B

GO Terms for Postherpetic Neuralgia

Cellular components related to Postherpetic Neuralgia according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 endoplasmic reticulum GO:0005783 9.65 HLA-A HLA-B HLA-DRB1
2 Golgi apparatus GO:0005794 9.63 HLA-A HLA-B HLA-DRB1
3 Golgi membrane GO:0000139 9.5 HLA-A HLA-B HLA-DRB1
4 early endosome membrane GO:0031901 9.43 HLA-A HLA-B
5 cell surface GO:0009986 9.43 HLA-A HLA-B HLA-DRB1
6 phagocytic vesicle membrane GO:0030670 9.4 HLA-A HLA-B
7 recycling endosome membrane GO:0055038 9.37 HLA-A HLA-B
8 MHC class I protein complex GO:0042612 9.16 HLA-A HLA-B
9 ER to Golgi transport vesicle membrane GO:0012507 9.13 HLA-A HLA-B HLA-DRB1
10 integral component of lumenal side of endoplasmic reticulum membrane GO:0071556 8.8 HLA-A HLA-B HLA-DRB1

Biological processes related to Postherpetic Neuralgia according to GeneCards Suite gene sharing:

(show all 11)
id Name GO ID Score Top Affiliating Genes
1 immune response GO:0006955 9.61 HLA-A HLA-B HLA-DRB1
2 immune system process GO:0002376 9.58 HLA-A HLA-B HLA-DRB1
3 viral process GO:0016032 9.54 HLA-A HLA-B HLA-DRB1
4 regulation of immune response GO:0050776 9.49 HLA-A HLA-B
5 antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent GO:0002479 9.48 HLA-A HLA-B
6 type I interferon signaling pathway GO:0060337 9.46 HLA-A HLA-B
7 antigen processing and presentation of peptide antigen via MHC class I GO:0002474 9.32 HLA-A HLA-B
8 antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent GO:0002480 9.26 HLA-A HLA-B
9 protection from natural killer cell mediated cytotoxicity GO:0042270 9.16 HLA-A HLA-B
10 interferon-gamma-mediated signaling pathway GO:0060333 9.13 HLA-A HLA-B HLA-DRB1
11 antigen processing and presentation GO:0019882 8.8 HLA-A HLA-B HLA-DRB1

Molecular functions related to Postherpetic Neuralgia according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 peptide antigen binding GO:0042605 8.8 HLA-A HLA-B HLA-DRB1

Sources for Postherpetic Neuralgia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....